Valo Health to Participate in Financial Times US Pharma and Biotech Summit
BOSTON, April 29, 2021 /PRNewswire/ -- Valo Health, LLC (Valo), the technology company that is using human-centric data, machine learning computation and life science expertise to transform and accelerate the drug discovery and development process, today announced that David Berry, Ph.D., founder and Chief Executive Officer of Valo will participate in a panel discussion during the Financial Times US Pharma and Biotech Summit on Wednesday, May 5, 2021 at 11:30 AM ET.
The panel, "Navigating the pharma investment landscape," will focus on emerging investment trends in the areas of therapeutics, technology, and M&A.
View original content to download multimedia:http://www.prnewswire.com/news-releases/valo-health-to-participate-in-financial-times-us-pharma-and-biotech-summit-301280400.html
SOURCE Valo Health, LLC